Shows chloroquine increases survival against Cryptococcus neoformans infection in mice, suggesting a novel treatment strategy.
Although the pathogenesis of cerebral cryptococcosis is poorly understood, local immune cells, such as microglia and astrocytes, likely play a critical role in containing infection, Chloroquine (CQ) is a weak base that accumulates within acidic vacuoles and increases their pH. Consequently, proteolytic activity of lysosomal enzymes and intracellular iron release/availability are impaired, resulting in decreased availability of nutrients crucial to microorganism survival and growth in the host, We found that CQ enhances BV2 microglial-cell-mediated anticryptococcal activity in vitro, The phenomenon is (i) evident when both unopsonized and opsonized microorganisms are used and (ii) mimicked by NH4Cl, another weak base, and by bafilomycin A(1), an inhibitor of vacuolar-type H+-ATPases. In vivo, intracerebral administration of CQ before lethal local challenge with Cryptococcus neoformans results in a significant augmentation of median survival time and a marked reduction of yeast growth in the brain and is associated with the enhancement of local interleukin 1 beta (IL-1 beta) and 1L-6 mRNA transcripts, Overall, these results provide the first evidence that CQ enhances anticryptococcal host defenses.
No takes yet. Share an insight, caveat, or question.
R et al. (1997) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: